| Code | 2371C | ||||||||||
| MA number | 44/0172/14-S | ||||||||||
| Product Form: | con inf 1x25 ml/500 mg (liek.inj.skl.) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | glass vial | ||||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 24.07.2014 |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Etopozid Accord 20 mg/ml_04/2019.doc.doc
|
| PIL: |
PIL_Etopozid Accord 20 mg_ml infúzny koncentrát_03.2022.pdf
|
| Dokument: |
DHPC_Etoposid_01.02.2024.pdf
|
| Safety feature | Yes |
| Data update: | 26.09.2019 |
